Latest Immunohistochemistry Stories
TUCSON, Ariz., Aug. 2, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today the launch of BenchMark ULTRA with new Ultimate Reagent Access (URA).
TUCSON, Ariz., July 26, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc.
IRVINE, Calif., June 28, 2011 /PRNewswire/ -- GeneTex, a leading manufacturer of high quality antibodies, is pleased to announce that they will be launching a full line of zebrafish antibodies. Zebrafish have been increasingly utilized as a model organism for scientific research.
TUCSON, Ariz., June 14, 2011 /PRNewswire/ -- Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today that the FDA approved the INFORM HER2 Dual ISH DNA Probe cocktail assay (HER2 Dual ISH) for commercialization in the United States.
EXTON, Pa., March 29, 2011 /PRNewswire/ -- MorphotekÂ®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a collaboration and license agreement with Biocare Medical, LLC.
Lung cancer is considered the 6th most common cause of cancer deaths in the United States.
An inexpensive and rapid testing method can effectively identify a sub-group of never-smoking lung cancer patients whose tumors express a molecule associated with increased risk of disease progression or recurrence, US researchers have found.
Today a digitized, or computerized, form of immunohistochemistry (IHC) is revolutionizing the clinical pathology industry, helping pathologists make diagnoses with improved accuracy, efficiency and speed are invaluable to the doctors and their patients who rely on pathology results.
- The parings of haberdine; also, any kind of fragments.